Update Announcement regarding Presmed Australia’s investment in DEVOCLEA
Update Announcement regarding Presmed Australia’s investment in DEVOCLEA ADVANCED HEALTH LIMITED (Incorporated in the Republic of South Africa) (Registration number 2013/059246/06) (“the Company” or “Advanced Health”) ISIN Code: ZAE000189049 JSE Code: AVL UPDATE ANNOUNCEMENT REGARDING PRESMED AUSTRALIA’S INVESTMENT IN DEVOCLEA Transaction update Shareholders are referred to the detailed terms and cautionary announcement that was released on SENS on 11 June 2021 and the update announcement released on 30 June 2021 regarding Presmed Australia Pty Limited’s (“PMA”), acquisition of a 20% interest in the Devonport Eye Hospital (NWC) Pty Ltd (“Devonport Eye Hospital”) and Clearvis Pty Ltd (“Clearvis”) (collectively “DEVOCLEA”), (the “Transaction”). Shareholders are advised that all the conditions precedents were fulfilled on 7 July 2021. Profit and Net Asset Values attributable to DEVOCLEA The net assets of DEVOCLEA as per the unaudited financial statements for the 12 months ended 30 June 2020, were AUD 1,575,126 (approximately ZAR16 341 302). The profit before tax attributable to the net assets of DEVOCLEA for the same period were AUD 2,081,638 (approximately ZAR21 596 162). The unaudited annual financial statements for DEVOCLEA were prepared in accordance with Australian Accounting Standards and Interpretations. Renewal of cautionary announcement As previously advised, the additional Transaction consideration amount will be disclosed in a further SENS announcement, once it has been determined. Pending the finalisation of the additional Transaction consideration amount, shareholders are advised to continue to exercise caution when dealing in the company’s securities until such further announcement has been released. Johannesburg 8 July 2021 Designated Advisor Grindrod Bank Limited Date: 08-07-2021 09:30:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.